ABBV has been in the news 375% more than usual
Jul 30, 2025, 6:31 PM
9.25%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: President Trump is planning to impose tariffs of up to 200% on imported pharmaceuticals, which could affect companies like AbbVie and Eli Lilly. AbbVie is set to release its quarterly earnings report on July 31, 2025, which will be important for investors.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.